Why does hs-CRP matter?
Cholesterol tells you how much flammable material is in the building. It says nothing about whether anything is actually on fire.
Plenty of people have a clean lipid panel and a smoldering problem anyway. Their blood vessels are inflamed, their plaque is the unstable kind, their tissues are aging faster than their numbers suggest, and none of it shows up on a standard panel. Inflammation is the process underneath an enormous share of chronic disease, from heart attacks to diabetes to dementia, and for most of a lifetime it makes no noise at all.
hs-CRP is the most accessible way to listen for it. The "high-sensitivity" part is the whole point: ordinary CRP testing is built to detect the roaring inflammation of an infection, while the high-sensitivity assay picks up the faint, persistent signal of the low-grade inflammation that drives long-term disease. A standard panel measures the fuel. This one checks for smoke [1].
How hs-CRP actually works
Picture the town's fire brigade. When something catches anywhere, an infection, a wound, a patch of damaged artery wall, the alarm goes up and the brigade rolls into the streets to put it out. The liver is the station that calls them out, and C-reactive protein is the brigade itself, the engines you can count moving through the streets.
A sudden, town-wide turnout means a real blaze: a flu, an injury, an acute infection. The engines flood the streets, knock it down, and return to the station. That is ordinary CRP, and it is not what we are screening for.
What matters for the long run is quieter and more dangerous: a few engines always out, day after day, year after year, never quite standing down. Not a blaze, just a thin haze of smoke that never lifts over the town. Somewhere a fire is smoldering and never fully dying, visceral fat, a roughened artery wall, inflamed gums, a metabolism under strain, and so the brigade can never fully come home. That permanent low haze is what the high-sensitivity test is built to catch, and it is the kind of fire that wears a town down slowly, building by building.
The reading cannot tell you which building is smoldering. It tells you, unmistakably, that somewhere something is still burning.
C-reactive protein is made by the liver, and it is produced on demand in response to a signaling molecule called interleukin-6. When immune cells anywhere in the body encounter damage or infection, they release interleukin-6 into the blood, the liver receives that signal, and within hours it ramps up CRP production [2]. CRP then circulates and binds to the surfaces of dying cells and pathogens, flagging them for removal and activating the broader immune response.
This makes CRP a faithful summary of total inflammatory load. It does not measure any single source. It integrates all of them, which is exactly what makes it useful: a single number reflecting how much inflammatory signaling your body is doing right now.
The high-sensitivity assay matters because the levels that predict chronic disease are very low, often well under 1 mg/L, far below what older CRP tests could reliably read. At these concentrations, the number reflects the background hum of inflammation rather than any acute event. The usual sources of that hum are familiar: visceral fat, which behaves like an inflammatory organ and secretes interleukin-6 directly; insulin resistance; a diet high in refined carbohydrate; smoking; poor sleep; gum disease; and the slow, generalized rise in inflammatory tone that accompanies aging itself, sometimes called inflammaging [3].
Inflammation is also meant to switch off once its job is done, and that resolution is an active process, not just the absence of a signal. The omega-3 fatty acids EPA and DHA supply the raw material for the specialized molecules that carry it out, which is part of why a higher omega-3 status tends to track with a lower CRP [4].
The link between low-grade inflammation and cardiovascular events is one of the most replicated findings in the field. In a meta-analysis pooling more than 160,000 people without a history of vascular disease, each increment of hs-CRP tracked with a higher risk of coronary heart disease, ischemic stroke, and vascular death [1]. The association persisted across populations and held even among people whose cholesterol was unremarkable.
That last point reframed how risk is understood. Lowering atherogenic particles is essential, but a meaningful share of cardiovascular events still occurs in people whose lipids are well managed, and elevated inflammation identifies much of that remaining risk. This is the concept of residual inflammatory risk: two people with identical cholesterol can carry very different danger, and inflammation is part of what separates them [3].
CRP's strength and its weakness are the same trait. Because it integrates inflammation from every source, it is sensitive but not specific. A value above roughly 10 mg/L usually signals an acute event, a cold, an injury, a flare of something, rather than chronic cardiovascular risk, and the test should simply be repeated once recovered. The meaningful screening range sits below that, where a persistently elevated reading points to a chronic, modifiable process. Whether CRP itself drives damage or mainly marks the interleukin-6 pathway that does is still debated, but for practical purposes it does the job that matters: it tells you the fire is lit, early enough to do something about it.
Reference range & target
Lab reference ranges use wider thresholds; the evidence-informed target is tighter, set where long-term risk is lowest. Context matters: family history, other biomarkers, and inflammatory markers all modify interpretation.
How hs-CRP connects to everything else
hs-CRP does not exist in isolation. It is a downstream signal of several converging metabolic processes, which is why treating it effectively means understanding its inputs.
When hs-CRP moves
A single hs-CRP can be thrown off by a recent cold, a minor injury, or a hard workout. The standard approach is to average two readings taken at least two weeks apart, when you are well, before drawing any conclusion.
Acute illness or injury can raise CRP many times over. Wait until you have been recovered for about two weeks so the number reflects your baseline, not a passing event.
Hard or unaccustomed training causes muscle inflammation that can elevate CRP for a day or two. Avoid a strenuous session in the 24 to 48 hours before testing.
CRP responds to sustained change in visceral fat, fitness, and diet across weeks to months. It is a trend marker, so retest on that timescale rather than expecting an overnight shift.
Pregnancy, estrogen therapy, and higher body fat all lift baseline CRP. None of these are emergencies, but they are worth knowing when you interpret a result.
How to improve your hs-CRP
Listed by strength of evidence, not by how loudly they're sold.
Inflammation is the road that many different diseases travel to reach you. Heart disease, diabetes, and cognitive decline look unrelated from the outside, but underneath they share this slow, smoldering process, and for years it asks nothing of you and gives no warning.
hs-CRP is a way to hear it early. It will not name the source, and it does not need to. What it tells you is whether something is burning, and almost everything that turns the number down, losing abdominal fat, moving your body, eating real food, sleeping, not smoking, is already in your hands. Few biomarkers respond as quickly or as fully to the ordinary decisions of a life. This one rewards them. The fire that never starts is the one that never costs you anything.
hs-CRP is available as a standalone, direct-access test through Ulta Lab Tests, which runs your samples on Quest Diagnostics' labs. No doctor's order needed, and the price is all-inclusive, with no separate lab or draw fees. Price last verified June 25, 2026. NY, NJ, and RI residents: Ulta cannot serve these states.
No. hs-CRP itself does not require fasting. It is often drawn alongside a lipid or metabolic panel that does, so you may end up fasting for the other tests in the same draw.
Below 1.0 mg/L is considered low cardiovascular risk, 1.0 to 3.0 is average, and above 3.0 is high. A longevity-minded target sits under 1.0, and ideally under 0.5.
Not from one reading. A recent cold, injury, or hard workout can raise it temporarily, and a value above 10 mg/L usually means an acute event rather than chronic risk. Repeat the test in two weeks when you are well before concluding anything.
They measure the same protein. Regular CRP is calibrated for the high levels of acute infection. The high-sensitivity assay reads the much lower levels that matter for chronic cardiovascular and metabolic risk.
Yes, and quickly relative to most markers. Losing visceral fat, exercising, improving diet, and quitting smoking can move it substantially within weeks to months.
Not entirely. CRP is one window on a complex system and will not capture every kind of inflammation. But it is the best-validated, lowest-cost single marker for the low-grade inflammation that tracks with long-term risk.
- 1.Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. doi:10.1016/S0140-6736(09)61717-7
- 2.Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812. doi:10.1172/JCI200318921
- 3.Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J. 2016;37(22):1720-1722. doi:10.1093/eurheartj/ehw024
- 4.Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. *Biochemical Society Transactions*. 2017;45(5):1105-1115. doi:10.1042/BST20160474